This systematic review and meta-analysis
Reference Rebchuk, Kim, Rizzuto, Richards, Brakel and Haw1
addresses an important but often overlooked aspect of recovery after aneurysmal subarachnoid hemorrhage (aSAH): long-term mental health and the risk of suicide. The authors should be commended for examining an outcome that is highly relevant to patients yet rarely incorporated into traditional assessments of aSAH recovery, which often focus on mortality, angiographic outcomes, or functional status alone.
The principal finding is that survivors of aSAH experience a significantly increased relative risk of death by suicide compared with the general population. At the same time, the study appropriately emphasizes that suicide remains an uncommon outcome after aSAH. This distinction deserves particular attention. Relative risk estimates of 1.4 to 1.8 may appear alarming in isolation, but the absolute event rate remains low, with only 90 suicides identified among more than 20,000 survivors across both included studies. Framing the findings in terms of both relative and absolute risk helps avoid unintended exaggeration while preserving the important clinical message.
The study also highlights a broader limitation in the neurovascular literature. Despite decades of research in aSAH, remarkably little is known about the long-term psychiatric trajectory of survivors. Functional scales such as the modified Rankin Scale are widely used as outcome measures, yet they incompletely capture depression, anxiety, cognitive dysfunction, social isolation, and diminished quality of life. Patients who are categorized as having favorable functional outcomes may still experience substantial psychological morbidity. The present work therefore reinforces the need for outcome frameworks that extend beyond traditional neurological disability metrics.
An additional point worthy of consideration is the limited evidence base underpinning the analysis. Only two studies met the inclusion criteria, both derived from Nordic populations with universal healthcare systems and robust national registries. While these databases provide exceptional follow-up and outcome ascertainment, the generalizability of the findings to other healthcare environments remains uncertain. More importantly, the available data do not permit identification of patient-level predictors of suicide, timing of highest risk beyond limited observations, or the contribution of factors such as disability severity, cognitive impairment, socioeconomic status, or pre-existing psychiatric disease.
Overall, this study provides an important reminder that successful aneurysm treatment does not necessarily equate to complete recovery and that long-term psychosocial outcomes deserve greater attention in both research and clinical follow-up.
You have
Access
This systematic review and meta-analysis Reference Rebchuk, Kim, Rizzuto, Richards, Brakel and Haw1 addresses an important but often overlooked aspect of recovery after aneurysmal subarachnoid hemorrhage (aSAH): long-term mental health and the risk of suicide. The authors should be commended for examining an outcome that is highly relevant to patients yet rarely incorporated into traditional assessments of aSAH recovery, which often focus on mortality, angiographic outcomes, or functional status alone.
The principal finding is that survivors of aSAH experience a significantly increased relative risk of death by suicide compared with the general population. At the same time, the study appropriately emphasizes that suicide remains an uncommon outcome after aSAH. This distinction deserves particular attention. Relative risk estimates of 1.4 to 1.8 may appear alarming in isolation, but the absolute event rate remains low, with only 90 suicides identified among more than 20,000 survivors across both included studies. Framing the findings in terms of both relative and absolute risk helps avoid unintended exaggeration while preserving the important clinical message.
The study also highlights a broader limitation in the neurovascular literature. Despite decades of research in aSAH, remarkably little is known about the long-term psychiatric trajectory of survivors. Functional scales such as the modified Rankin Scale are widely used as outcome measures, yet they incompletely capture depression, anxiety, cognitive dysfunction, social isolation, and diminished quality of life. Patients who are categorized as having favorable functional outcomes may still experience substantial psychological morbidity. The present work therefore reinforces the need for outcome frameworks that extend beyond traditional neurological disability metrics.
An additional point worthy of consideration is the limited evidence base underpinning the analysis. Only two studies met the inclusion criteria, both derived from Nordic populations with universal healthcare systems and robust national registries. While these databases provide exceptional follow-up and outcome ascertainment, the generalizability of the findings to other healthcare environments remains uncertain. More importantly, the available data do not permit identification of patient-level predictors of suicide, timing of highest risk beyond limited observations, or the contribution of factors such as disability severity, cognitive impairment, socioeconomic status, or pre-existing psychiatric disease.
Overall, this study provides an important reminder that successful aneurysm treatment does not necessarily equate to complete recovery and that long-term psychosocial outcomes deserve greater attention in both research and clinical follow-up.
Competing interests
None.